{"id":840263,"date":"2025-04-22T16:38:56","date_gmt":"2025-04-22T20:38:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/"},"modified":"2025-04-22T16:38:56","modified_gmt":"2025-04-22T20:38:56","slug":"jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/","title":{"rendered":"Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">DUBLIN<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">April 22, 2025<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 first quarter financial results on <span class=\"xn-chron\">Tuesday, May 6, 2025<\/span>, after the close of the U.S. financial markets. Company management will host a live audio webcast at <span class=\"xn-chron\">4:30 p.m. ET<\/span> \/ <span class=\"xn-chron\">9:30 p.m. IST<\/span> to discuss 2025 first quarter financial results and provide a business and financial update. \u00a0<\/p>\n<p>\n        <b>Audio webcast\/conference call:<br \/><\/b><br \/>\n        <span>U.S. Dial-In Number: +1 800 715 9871<br \/><\/span>Ireland Dial-In Number: +353 1800 943 926<br \/>Additional global dial-in numbers are available <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4410337-1&amp;h=2553114529&amp;u=https%3A%2F%2Fevents.q4irportal.com%2Fcustom%2Faccess%2F2324%2F&amp;a=here\" target=\"_blank\" rel=\"nofollow\">here<\/a>.<br \/>Passcode: 5080203<\/p>\n<p>Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4410337-1&amp;h=721976994&amp;u=https%3A%2F%2Finvestor.jazzpharma.com%2Finvestors%2Fevents-presentations&amp;a=https%3A%2F%2Finvestor.jazzpharma.com%2Finvestors%2Fevents-presentations\" target=\"_blank\" rel=\"nofollow\">https:\/\/investor.jazzpharma.com\/investors\/events-presentations<\/a>. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.<\/p>\n<p>A replay of the webcast will be available via the Investors section of the Jazz Pharmaceuticals website at <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4410337-1&amp;h=721976994&amp;u=https%3A%2F%2Finvestor.jazzpharma.com%2Finvestors%2Fevents-presentations&amp;a=https%3A%2F%2Finvestor.jazzpharma.com%2Finvestors%2Fevents-presentations\" target=\"_blank\" rel=\"nofollow\">https:\/\/investor.jazzpharma.com\/investors\/events-presentations<\/a>.\u00a0<\/p>\n<p>\n        <b><br \/>\n          <u>About Jazz Pharmaceuticals<br \/><\/u><br \/>\n        <\/b>Jazz Pharmaceuticals plc\u00a0(Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases \u2014 often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in\u00a0Dublin, Ireland\u00a0with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4410337-1&amp;h=1453634778&amp;u=http%3A%2F%2Fwww.jazzpharmaceuticals.com%2F&amp;a=www.jazzpharmaceuticals.com\" target=\"_blank\" rel=\"nofollow\">www.jazzpharmaceuticals.com<\/a>\u00a0for more information.<\/p>\n<p>\n        <b>Contacts:<\/b>\n      <\/p>\n<p>\n        <b>Investors:<\/b><br \/>\n        <br \/>\n        <span class=\"xn-person\">Jeff Macdonald<\/span><br \/>\n        <br \/>Exec Dir, Investor Relations<br \/>Jazz Pharmaceuticals plc<br \/><a href=\"mailto:InvestorInfo@jazzpharma.com\" target=\"_blank\" rel=\"nofollow\">InvestorInfo@jazzpharma.com<\/a><br \/>Ireland\u00a0+353 1 634 3211<br \/>U.S.\u00a0+1 650 496 2717<\/p>\n<p>\n        <b>Media:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Kristin Bhavnani<\/span><br \/>\n        <br \/>Head of\u00a0Global Corporate Communications<br \/>Jazz Pharmaceuticals plc<br \/><a href=\"mailto:CorporateAffairsMediaInfo@jazzpharma.com\" target=\"_blank\" rel=\"nofollow\">CorporateAffairsMediaInfo@jazzpharma.com<\/a><br \/>Ireland\u00a0+353 1 637 2141<br \/>U.S.\u00a0+1 215 867 4948<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder8787\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_New_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_New_Logo.jpg\" title=\"Jazz Pharmaceuticals Logo (PRNewsFoto\/Jazz Pharmaceuticals plc) (PRNewsFoto\/Jazz Pharmaceuticals plc)\" alt=\"Jazz Pharmaceuticals Logo (PRNewsFoto\/Jazz Pharmaceuticals plc) (PRNewsFoto\/Jazz Pharmaceuticals plc)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=SF69891&amp;sd=2025-04-22\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025-302434748.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025-302434748.html<\/a><\/p>\n<p>SOURCE  Jazz Pharmaceuticals plc<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=SF69891&amp;Transmission_Id=202504221615PR_NEWS_USPR_____SF69891&amp;DateId=20250422\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire DUBLIN , April 22, 2025 \/PRNewswire\/ &#8212;\u00a0Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 first quarter financial results on Tuesday, May 6, 2025, after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. ET \/ 9:30 p.m. IST to discuss 2025 first quarter financial results and provide a business and financial update. \u00a0 Audio webcast\/conference call: U.S. Dial-In Number: +1 800 715 9871Ireland Dial-In Number: +353 1800 943 926Additional global dial-in numbers are available here.Passcode: 5080203 Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at https:\/\/investor.jazzpharma.com\/investors\/events-presentations. To ensure a timely connection, it is recommended that &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-840263","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire DUBLIN , April 22, 2025 \/PRNewswire\/ &#8212;\u00a0Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 first quarter financial results on Tuesday, May 6, 2025, after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. ET \/ 9:30 p.m. IST to discuss 2025 first quarter financial results and provide a business and financial update. \u00a0 Audio webcast\/conference call: U.S. Dial-In Number: +1 800 715 9871Ireland Dial-In Number: +353 1800 943 926Additional global dial-in numbers are available here.Passcode: 5080203 Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at https:\/\/investor.jazzpharma.com\/investors\/events-presentations. To ensure a timely connection, it is recommended that &hellip; Continue reading &quot;Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-22T20:38:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_New_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025\",\"datePublished\":\"2025-04-22T20:38:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/\"},\"wordCount\":331,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/272253\\\/Jazz_Pharmaceuticals_New_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/\",\"name\":\"Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/272253\\\/Jazz_Pharmaceuticals_New_Logo.jpg\",\"datePublished\":\"2025-04-22T20:38:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/272253\\\/Jazz_Pharmaceuticals_New_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/272253\\\/Jazz_Pharmaceuticals_New_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/","og_locale":"en_US","og_type":"article","og_title":"Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 - Market Newsdesk","og_description":"PR Newswire DUBLIN , April 22, 2025 \/PRNewswire\/ &#8212;\u00a0Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 first quarter financial results on Tuesday, May 6, 2025, after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. ET \/ 9:30 p.m. IST to discuss 2025 first quarter financial results and provide a business and financial update. \u00a0 Audio webcast\/conference call: U.S. Dial-In Number: +1 800 715 9871Ireland Dial-In Number: +353 1800 943 926Additional global dial-in numbers are available here.Passcode: 5080203 Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at https:\/\/investor.jazzpharma.com\/investors\/events-presentations. To ensure a timely connection, it is recommended that &hellip; Continue reading \"Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-22T20:38:56+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_New_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025","datePublished":"2025-04-22T20:38:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/"},"wordCount":331,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_New_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/","name":"Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_New_Logo.jpg","datePublished":"2025-04-22T20:38:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_New_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_New_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-first-quarter-financial-results-on-may-6-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/840263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=840263"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/840263\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=840263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=840263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=840263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}